Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hiroaki Musha is a pioneering surgeon whose research focuses on advancing minimally invasive techniques in colorectal and hepatobiliary surgery, with a particular emphasis on robotic and transanal approaches for rectal cancer. His work has significantly contributed to understanding the learning curve and functional outcomes of robotic rectal surgery. In his most-cited study (2023, 15 citations), he employed risk-adjusted cumulative summation analysis to map the 5-year institutional learning curve for robotic rectal procedures, providing critical benchmarks for surgical training and quality assurance. Dr. Musha’s 2021 investigation (11 citations) demonstrated potential urinary function benefits of initial robotic surgery over conventional laparoscopy during the introductory phase, offering evidence for patient-centered advantages even as surgeons gain proficiency. His early experience with robotic surgery for type I congenital dilatation of the bile duct (2015, 11 citations) showcases his versatility in applying robotic platforms to complex hepatobiliary cases. Additionally, his work on combining transanal total mesorectal excision with transabdominal robotic surgery (2021, 5 citations) explores synergistic strategies to improve oncological and functional outcomes in challenging rectal cancer cases. With a cumulative impact spanning over 40 citations, Dr. Musha’s research provides actionable insights for surgeons adopting robotic technologies, emphasizing both technical mastery and tangible patient benefits.